¿¬¼ö°ÁÂ
- ´ëÇÑ°ñ´Ù°øÁõÇÐȸ
- µî·ÏÀÏ : 2011-04-25 ÀÛ¼ºÀÚ : ´ëÇÑ°ñ´Ù°øÁõÇÐȸ
| ÀÏÁ¤ | 2011³â 05¿ù 01ÀÏ (ÀÏ) 9½Ã 00ºÐ |
|---|---|
| Àå¼Ò | ¼¿ï¾Æ»êº´¿ø 6Ãþ ´ë°´ç |
| ÁÖÃÖ | ´ëÇÑ°ñ´Ù°øÁõÇÐȸ |
| Âü°¡ºñ | 50,000¿ø |
| ¹®ÀÇó | |
| Âü¼®Àοø | 0¸í |
| ÷ºÎÆÄÀÏ |
ÇмúÇà»ç ¾È³»
»çÀüµî·Ï
µî·Ïºñ
* Æò»ýȸºñ³ª ¿¬È¸ºñ ³³ºÎ ÇØ ÁֽŠȸ¿ø²²¼´Â µî·Ï ¹«·á ÀÔ´Ï´Ù.
ÆòÁ¡ : ´ëÇÑÀÇ»çÇùȸ 6Á¡
¢Â Á¦ 8ȸ Expert Meeting
| - ÀÏ ½Ã : 2011³â 5¿ù 1ÀÏ(ÀÏ) |
| - Àå ¼Ò : ¼¿ï ¾Æ»êº´¿ø µ¿°ü 6Ãþ ´ë°´ç ¼Ò°´ç |
»çÀüµî·Ï | - »çÀüµî·Ï ¸¶°¨ÀÏ : 2011³â 4¿ù 25ÀÏ(¿ù) |
| - ÀԱݰèÁ : ±¹¹ÎÀºÇà 462237-01-002296 (¿¹±ÝÁÖ: ´ëÇÑ°ñ´Ù°øÁõÇÐȸ) |
| * »çÀüµî·Ï½Ã ¼º¸í, ¼Ò¼Ó, Àü°øºÐ¾ß, ÀÇ»ç¸éÇã¹øÈ£, ÁÖ¼Ò, ÀüȹøÈ£, Æѽº¹øÈ£, ¼Û±ÝÀÏÀ» ±âÀçÇØ Áֽñ⠹ٶø´Ï´Ù. |
µî·Ïºñ| ±¸ ºÐ | »çÀüµî·Ï | ´çÀϵî·Ï | |
| Á¤È¸¿ø | Á¤È¸¿ø Àü¹®ÀÇ,ÀüÀÓÀÇ,¹Ú»ç±Þ ¿¬±¸¿ø | 5¸¸¿ø | 7¸¸¿ø |
| Àü°øÀÇ,°£È£»ç,¼®»ç±Þ ÀÌ»ç ¿¬±¸¿ø | 4¸¸¿ø | 6¸¸¿ø | |
| ºñȸ¿ø, ÁØȸ¿ø |
Àü¹®ÀÇ,ÀüÀÓÀÇ,¹Ú»ç±Þ ¿¬±¸¿ø, ÀÇ·á Á¾»çÀÚ | 6¸¸¿ø | 8¸¸¿ø |
| Àü°øÀÇ,°£È£»ç,¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø | 5¸¸¿ø | 7¸¸¿ø | |
ÆòÁ¡ : ´ëÇÑÀÇ»çÇùȸ 6Á¡ ÇÁ·Î±×·¥
| 08:25-08:30 | °³È¸»ç |
| Session 1 : °ñ´Ù°øÁõÀÇ ÀÌÇØ ¹× Áø´Ü | ||
| 08:30-08:50 | Peak bone mass; recent update in Korea | ¿ÀÇÑÁø °üµ¿ÀÇ´ë |
| 08:50-09:10 | Role of vitamin D in osteoporosis | ±èÇÏ¿µ ¿ø±¤ÀÇ´ë |
| 09:10-09:30 | BMD - central and peripheral | ±è¹üÅà ¾ÆÁÖÀÇ´ë |
| 09:30-09:50 | ³«»ó À§ÇèÀÇ Æò°¡ ¹× ¿¹¹æ | ¹Îº´¿ì °è¸íÀÇ´ë |
| 09:50-10:00 | Discussion | |
| 10:00-10:20 | Coffee Break |
| Session 2 : ÈçÈ÷ º¸´Â °ñ´Ù°øÁõ À¯¹ß Áúȯ | ||
| 10:20-10:40 | Glucocorticoid-induced osteoporosis | ÁÖÁöÇö °¡Å縯ÀÇ´ë |
| 10:40-11:00 | Endocrine diseases; DM, thyroid etc. | ¹Ú¼Ò¿µ °üµ¿ÀÇ´ë |
| 11:00-11:20 | Inflammation and Osteoporosis | ¼Ã¢Èñ ¾ÆÁÖÀÇ´ë |
| 11:20-11:40 | Chronic kidney disease | ±Ç¿µÁÖ °í·ÁÀÇ´ë |
| 11:40-12:00 | ºÎÀΰú Áúȯ | ÀÌÁö¿µ °Ç±¹ÀÇ´ë |
| 12:00-12:20 | Discussion | |
| 12:20-13:30 | Lunch |
| Session 3 : °ñ´Ù°øÁõÀÇ Ä¡·á ¥° | ||
| 13:30-13:50 | Calcium Á¦Á¦ »ç¿ë¿¡ °ü·ÃµÈ ÃÖ±Ù ³í¶õ | ±Ç¹ÎÁ¤ ÀÎÁ¦ÀÇ´ë |
| 13:50-14:10 | SERM and Livial | ÀÌÇØÇõ ¼øõÇâÀÇ´ë |
| 14:10-14:30 | ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ®; ¾àÁ¦º° Â÷ÀÌÁ¡ ¹× drug holiday | ±è¼¼È °üµ¿ÀÇ´ë |
| 14:30-14:50 | °ñ´Ù°øÁõ Áõ·Ê ÅäÀÇ | ÀÌÀ¯¹Ì ¿¬¼¼ÀÇ´ë |
| 14:50-15:00 | Discussion | |
| 15:00-15:20 | Coffee Break |
| Session 4 : °ñ´Ù°øÁõÀÇ Ä¡·á ¥± | ||
| 15:20-15:40 | °Ç°º¸Çè ÀçÁ¤»óȲ°ú ¼ö°¡Á¤Ã¥ ¹æÇâ | ÇѸ¸È£ ±¹¹Î°Ç°º¸Çè°ü¸®°ø´Ü |
| 15:40-16:00 | ºñ±³Àû µå¹® °ñ´Ù°øÁõ¼º ºÎÀü °ñÀý | °íÇؼ® °¡Å縯ÀÇ´ë |
| 16:00-16:20 | Vertebroplasty - will do or not? | ¼Çü¿¬ Àü³²ÀÇ´ë |
| 16:20-16:40 | Implants and Fixation principles | ¹Ú±âö ÇѾçÀÇ´ë |
| 16:40-17:00 | °ñÀýÄ¡·á ÈÄÀÇ ÀçÈ° | ÀÓÀ翵 ¼¿ïÀÇ´ë |
| 17:00-17:20 | Discussion | ¡¡ |
¢Â Á¦ 8ȸ Expert Meeting
| 08:25-08:30 | °³È¸»ç |
| Session 1 : Ư¼ö»óȲÇÏ¿¡¼ÀÇ °ñ´Ù°øÁõ (Osteoporosis in special conditions) | ||
| 08:30-08:50 | osteoporosis management for patients with degenerative spinal disease |
ÀÌÀçÇù (¼¿ïÀÇ´ë) |
| 08:50-09:10 | natural course and treatment of kyphotic deformity after osteoporotic vertebral fracture | ¾çÁØ¿µ (Ãæ³²ÀÇ´ë) |
| 09:10-09:30 | osteoporosis management for patients with artificial joint | ±èÁØ½Ä (ÀÌÈÀÇ´ë) |
| 09:30-09:50 | osteoporosis in musculoskeletal tumor | ±èº´¼® (À»ÁöÀÇ´ë) |
| 09:50-10:00 | Discussion | |
| 10:00-10:20 | Coffee Break |
| Session 2 : Bone biology. (English session) | ||
| 10:20-10:40 | Osteoblast biology. JT Koh (Korea) | Jeong-Tae Koh(korea) °íÁ¤Å (Àü³²Ä¡´ë) |
| 10:40-11:10 | Roles of osteocytes in phosphate homeostasis. | Toshimi Michigami (Japan) |
| 11:10-11:30 | Bone decalcification versus soft tissue calcification. | Daewon Jeong (Korea) Á¤´ë¿ø (¿µ³²´ë) |
| 11:30-12:00 | Directed induction of hyaline chondrogenic cells from mouse adult dermal fibroblast culture by defined factors. |
Noriyuki Tsumaki (Japan) |
| 12:00-12:20 | Discussion | |
| 12:20-13:30 | Lunch |
| Session 3 : Sarcopenia. | ||
| 13:30-13:50 | Definition and Epidemiology | ¹Ú¼®¿ø (Â÷ÀÇ°úÇдëÇÐ) |
| 13:50-14:10 | Basic pathophysiology of sarcopenia | ¼Û¿í (¼¿ï´ë ü´ë) |
| 14:10-14:30 | Sarcopenic Obesity and Diabetes | Ãְ湬 (°í·ÁÀÇ´ë) |
| 14:30-14:50 | Sarcopenia and Osteoporosis | È«»ó¸ð (ÇѾçÀÇ´ë) |
| 14:50-15:00 | Discussion | |
| 15:00-15:20 | Coffee Break |
| Session 4 : Understanding biotherapy using monoclonal antibody. | ||
| 15:20-15:50 | Where is the cutting edge in therapeutic antibody development? | Á¤ÁØÈ£ (¼¿ïÀÇ´ë) |
| 15:50-16:10 | Use of monoclonal antibody in ovary cancer treatment | ¼»ó¼ö (±¹¸³¾Ï¼¾ÅÍ »êºÎÀΰú) |
| 16:10-16:30 | Role of monoclonal antibody in rheumatoid arthritis | Â÷ÈƼ® (¼º±Õ°üÀÇ´ë) |
| 16:30-17:00 | Implication of monoclonal antibodies in managing osteoporosis. | ¹é±âÇö (°¡Å縯ÀÇ´ë) |
| 17:00-17:20 | Discussion | ¡¡ |
